The Maximizing Opioid Recovery Emergency (MORE) Savings Act aims to make opioid addiction treatments more affordable by eliminating out-of-pocket costs for patients. It proposes a Medicare model in 15 states to remove copayments and deductibles for opioid-related services, including medications, behavioral health services, and recovery support. Additionally, the bill mandates that private health insurance plans cover these services without cost-sharing and increases federal Medicaid funding for medication-assisted treatment.
Supporters of the MORE Savings Act commend its comprehensive approach to tackling the opioid crisis by reducing financial barriers to treatment. They highlight the bill's potential to improve access to essential services for individuals struggling with opioid addiction, particularly in states with high overdose rates and significant rural populations.
Critics of the MORE Savings Act express concerns about the financial implications of eliminating cost-sharing for opioid treatments. They argue that the increased federal spending required to support these measures could strain public resources and question the effectiveness of such policies in addressing the root causes of the opioid epidemic.
All donations are from employees of Applied Materials, Inc., indicating a potential conflict of interest if the MORE Savings Act benefits this company.
Top industries and organizations funding Madeleine Dean, from FEC data.
Source: FEC campaign finance records
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $240,000,000 |
| Total from overlapping industries | $240,000,000 | ||
Top industries funding Madeleine Dean, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
